Evidence map›Paper›PMID 32514397›Full record

ArticleIDCases2020

High positive HIV serology results can still be false positive.

Joanna Reid, Gert Van Zyl, Michael Linström, Stephen Korsman, Gert Marais, Wolfgang Preiser

Open access · goldAbstract readCase Reports
In one paragraph

Article in IDCases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. The Performance of the Current Algorithm of HIV Diagnosis.Iranian journal of public health · 2024
    Article
  2. Increase in False-Positive Fourth-Generation Human Immunodeficiency Virus Tests in Patients With Coronavirus Disease 2019.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joanna ReidDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, South Africa.
Gert Van ZylDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, South Africa.
Michael LinströmDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, South Africa.
Stephen KorsmanDivision of Medical Virology, University of Cape Town and Groote Schuur National Health Laboratory Service, South Africa.
Gert MaraisDivision of Medical Virology, University of Cape Town and Groote Schuur National Health Laboratory Service, South Africa.
Wolfgang PreiserDivision of Medical Virology, Department of Pathology, Stellenbosch University and National Health Laboratory Service Tygerberg, South Africa.
National Health Laboratory Service · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The consequences of falsely reactive HIV test results can be significant, for patients and healthcare providers. This case describes a diagnostic investigation of a patient with pronounced discordant HIV serological results, to determine HIV status. The fourth generation serological screening assay (Roche COBAS Elecsys HIV combiPT) had high positive results but confirmatory testing was negative (Abbott HIV Ag/Ab Combo). Five separate samples over 13 days were tested using multiple fourth generation HIV immunoassays and molecular tests for HIV-1 and HIV-2. Potential causes of falsely reactive serological results were investigated. Samples were sent to the manufacturer for analysis. The screening assay was positive on all samples with a very high signal to cut-off ratio (S/CO) of greater than 400. However, multiple serological and molecular assays did not detect HIV-1 or HIV-2 specific antibodies, antigen or nucleic acid. A recombinant immunochromatographic assay had faint reactivity to gp41 peptide and the manufacturer investigation reported cross-reactivity to one of the screening assay's synthetic peptides. Possible causes of the false positive result include cross reactivity to other antigens, including prior schistosomiasis infection, or the patient's previously excised ameloblastoma (a rare germ cell tumor of the jaw). This is a rare case of false high positive results on fourth-generation HIV serology testing due to high level non-specific reactivity to an isolated synthetic peptide component of the assay. It highlights the need for confirmatory testing even in settings with HIV high prevalence and awareness that false-positive serological results may have a high S/CO.

Indexed as

False positive HIV serologyHIV diagnosisHIV ElisaHIV serologyHuman immunodeficiency virus

Identifiers

PMID32514397
PMCPMC7267741
OpenAlexW3030692161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.